T. Broten

发表

Ultradian oscillations in blood pressure and heart rate in free-running dogs.

J. Zehr, A. Livnat, T. Broten, 1984, The American journal of physiology.

Statistical criteria for using short-term measurements as an index of 24-hour mean arterial pressure in unanesthetized unrestrained dogs.

J. Zehr, A. Livnat, T. Broten, 1988, Life sciences.

4-Amino-2-[4-[1-(benzyloxycarbonyl)-2(S)- [[(1,1-dimethylethyl)amino]carbonyl]-piperazinyl]-6, 7-dimethoxyquinazoline (L-765,314): a potent and selective alpha1b adrenergic receptor antagonist.

M. Bock, R. Chang, M. Patane, 1998, Journal of medicinal chemistry.

Cardiovascular and Renal Review: Pharmacology of Angiotensin II Receptor Antagonists: Comparison with Renin Inhibitors and Angiotensin-Converting Enzyme Inhibitors

T. Broten, P. Siegl, S. Kivlighn, 1994 .

Selective alpha1a adrenergic receptor antagonists based on 4-aryl-3,4-dihydropyridine-2-ones.

J. Barrow, R. Freidinger, R. Chang, 2000, Bioorganic & medicinal chemistry letters.

4-Oxospiro[benzopyran-2,4′-piperidines] as selective α1a-adrenergic receptor antagonists

M. Bock, R. Chang, T. Broten, 1999 .

Design and synthesis of N-alkylated saccharins as selective α-1a adrenergic receptor antagonists☆

R. Chang, Tsing-bau Chen, J. Huff, 1998 .

Synergistic action of myocardial oxygen and carbon dioxide in controlling coronary blood flow.

E. Feigl, D. Fullerton, T. Broten, 1991, Circulation research.

Role of endothelium-derived relaxing factor in parasympathetic coronary vasodilation.

S. Moncada, E. Feigl, T. Broten, 1992, The American journal of physiology.

In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.

W. Greenlee, A. Patchett, P. Chakravarty, 1995, American journal of hypertension.

Simple high-performance liquid chromatographic method to analyze serum creatinine has several advantages over the Jaffé picric acid reaction as demonstrated with a cimetidine dose response in rhesus monkeys.

T. Broten, J. Cook, M. Holahan, 2001, Journal of chromatography. B, Biomedical sciences and applications.

In Vitro and in Vivo Evaluation of Dihydropyrimidinone C-5 Amides as Potent and Selective α1A Receptor Antagonists for the Treatment of Benign Prostatic Hyperplasia

J. Barrow, K. Rittle, R. Freidinger, 2000 .

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinones.

R. Chang, P. Kling, B. Lagu, 1999, Journal of medicinal chemistry.

Design and Synthesis of Novel α1a Adrenoceptor-Selective Dihydropyridine Antagonists for the Treatment of Benign Prostatic Hyperplasia

R. Chang, T. Branchek, C. Forray, 1998 .

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series.

R. Chang, P. Kling, B. Lagu, 1999, Journal of medicinal chemistry.

De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailability.

A. D. Rodrigues, R. Chang, B. Lagu, 2000, Journal of medicinal chemistry.

Beta-receptor subtypes in the canine coronary circulation.

M. Trivella, E. Feigl, T. Broten, 1990, The American journal of physiology.

Role of myocardial oxygen and carbon dioxide in coronary autoregulation.

E. Feigl, T. Broten, 1992, The American journal of physiology.

In vitro and in vivo evaluation of dihydropyrimidinone C-5 amides as potent and selective alpha(1A) receptor antagonists for the treatment of benign prostatic hyperplasia.

J. Barrow, K. Rittle, R. Freidinger, 2000, Journal of medicinal chemistry.

3-(1-piperazinyl)-4,5-dihydro-1H-benzo[g]indazoles: high affinity ligands for the human dopamine D4 receptor with improved selectivity over ion channels.

P. Leeson, I. Collins, M. Rowley, 1998, Bioorganic & medicinal chemistry.

In vivo pharmacology of an angiotensin AT1 receptor antagonist with balanced affinity for angiotensin AT2 receptors

W. Greenlee, R. Chang, R. Gibson, 1995 .

Baroreflex modulation of ultradian oscillations of blood pressure and heart rate in unanesthetized dogs.

J. Zehr, T. Broten, 1989, Chronobiologia.

Design and Synthesis of Novel α1a Adrenoceptor-Selective Antagonists. 2. Approaches To Eliminate Opioid Agonist Metabolites via Modification of Linker and 4-Methoxycarbonyl-4-phenylpiperidine Moiety1,2

M. Bock, R. Freidinger, B. Lagu, 1999 .